A detailed history of Boenning & Scattergood, Inc. transactions in Sanofi stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 19,346 shares of SNY stock, worth $909,455. This represents 0.16% of its overall portfolio holdings.

Number of Shares
19,346
Previous 19,348 0.01%
Holding current value
$909,455
Previous $736,000 34.92%
% of portfolio
0.16%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

SELL
$38.86 - $48.55 $77 - $97
-2 Reduced 0.01%
19,346 $993,000
Q2 2022

Jul 13, 2022

BUY
$48.99 - $57.46 $97 - $114
2 Added 0.01%
19,348 $968,000
Q1 2022

Apr 14, 2022

BUY
$48.48 - $53.65 $21,137 - $23,391
436 Added 2.31%
19,346 $993,000
Q4 2021

Jan 18, 2022

BUY
$47.07 - $52.35 $47 - $52
1 Added 0.01%
18,910 $947,000
Q3 2021

Oct 21, 2021

SELL
$47.89 - $53.12 $47 - $53
-1 Reduced 0.01%
18,909 $911,000
Q2 2021

Jul 21, 2021

BUY
$49.36 - $54.25 $98 - $108
2 Added 0.01%
18,910 $996,000
Q4 2020

Jan 20, 2021

BUY
$45.3 - $51.62 $12,684 - $14,453
280 Added 1.5%
18,908 $919,000
Q2 2020

Jul 14, 2020

SELL
$42.91 - $52.5 $222,402 - $272,107
-5,183 Reduced 21.77%
18,628 $951,000
Q1 2020

Apr 13, 2020

SELL
$38.02 - $51.66 $45,624 - $61,991
-1,200 Reduced 4.8%
23,811 $1.04 Million
Q2 2019

Jul 15, 2019

BUY
$40.43 - $44.3 $646 - $708
16 Added 0.06%
25,011 $1.08 Million
Q4 2018

Jan 22, 2019

BUY
$41.48 - $45.59 $30,404 - $33,417
733 Added 3.02%
24,995 $1.09 Million
Q3 2018

Oct 05, 2018

SELL
$40.0 - $44.84 $7,000 - $7,847
-175 Reduced 0.72%
24,262 $1.08 Million
Q2 2018

Aug 13, 2018

BUY
$37.63 - $41.22 $919,564 - $1.01 Million
24,437 New
24,437 $978,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $118B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Boenning & Scattergood, Inc. Portfolio

Follow Boenning & Scattergood, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.